Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)

CHESTER, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT - News) today announced that the Food and Drug Administration (FDA) approved its supplemental New Drug Application for a grape-flavored formulation of Delsym Extended-Release Suspension on Friday, Sept. 28, 2007. The Company will immediately commence distribution of grape Delsym product to its trade customers.